233 related articles for article (PubMed ID: 3971637)
1. Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.
Eichelbaum M; Tomson T; Tybring G; Bertilsson L
Clin Pharmacokinet; 1985; 10(1):80-90. PubMed ID: 3971637
[TBL] [Abstract][Full Text] [Related]
2. Early stage autoinduction of carbamazepine metabolism in humans.
Bernus I; Dickinson RG; Hooper WD; Eadie MJ
Eur J Clin Pharmacol; 1994; 47(4):355-60. PubMed ID: 7875188
[TBL] [Abstract][Full Text] [Related]
3. Carbamazepine-10,11-diol steady-state serum levels and renal excretion during carbamazepine therapy in adults and children.
Bourgeois BF; Wad N
Ther Drug Monit; 1984; 6(3):259-65. PubMed ID: 6506133
[TBL] [Abstract][Full Text] [Related]
4. Single-dose kinetics and metabolism of carbamazepine-10,11-epoxide.
Tomson T; Tybring G; Bertilsson L
Clin Pharmacol Ther; 1983 Jan; 33(1):58-65. PubMed ID: 6848300
[TBL] [Abstract][Full Text] [Related]
5. Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
Spina E; Tomson T; Svensson JO; Faigle JW; Bertilsson L
Ther Drug Monit; 1988; 10(4):382-5. PubMed ID: 3201523
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine-danazol drug interaction: its mechanism examined by a stable isotope technique.
Krämer G; Theisohn M; von Unruh GE; Eichelbaum M
Ther Drug Monit; 1986; 8(4):387-92. PubMed ID: 3824425
[TBL] [Abstract][Full Text] [Related]
7. Carbamazepine: detection of another metabolite in serum, 9 hydroxymethyl-10-carbamoyl acridan.
Wad N; Guenat C; Krämer G
Ther Drug Monit; 1997 Jun; 19(3):314-7. PubMed ID: 9200773
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose.
Vree TB; Janssen TJ; Hekster YA; Termond EF; van de Dries AC; Wijnands WJ
Ther Drug Monit; 1986; 8(3):297-304. PubMed ID: 3750374
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in the absence and in the presence of enzyme induction by carbamazepine.
Britzi M; Perucca E; Soback S; Levy RH; Fattore C; Crema F; Gatti G; Doose DR; Maryanoff BE; Bialer M
Epilepsia; 2005 Mar; 46(3):378-84. PubMed ID: 15730535
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics: time-dependent changes--autoinduction of carbamazepine epoxidation.
Bertilsson L; Tomson T; Tybring G
J Clin Pharmacol; 1986; 26(6):459-62. PubMed ID: 3734137
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent metabolism of carbamazepine in humans.
Bernus I; Dickinson RG; Hooper WD; Eadie MJ
Epilepsy Res; 1996 Jul; 24(3):163-72. PubMed ID: 8832192
[TBL] [Abstract][Full Text] [Related]
12. Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients.
Nakajima Y; Saito Y; Shiseki K; Fukushima-Uesaka H; Hasegawa R; Ozawa S; Sugai K; Katoh M; Saitoh O; Ohnuma T; Kawai M; Ohtsuki T; Suzuki C; Minami N; Kimura H; Goto Y; Kamatani N; Kaniwa N; Sawada J
Eur J Clin Pharmacol; 2005 Mar; 61(1):25-34. PubMed ID: 15692831
[TBL] [Abstract][Full Text] [Related]
13. Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapy.
Eichelbaum M; Köthe KW; Hoffman F; von Unruh GE
Clin Pharmacol Ther; 1979 Sep; 26(3):366-71. PubMed ID: 466929
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat.
Panesar SK; Bandiera SM; Abbott FS
Drug Metab Dispos; 1996 Jun; 24(6):619-27. PubMed ID: 8781776
[TBL] [Abstract][Full Text] [Related]
15. Microsomal metabolism of carbamazepine and oxcarbazepine in liver and placenta.
Myllynen P; Pienimäki P; Raunio H; Vähäkangas K
Hum Exp Toxicol; 1998 Dec; 17(12):668-76. PubMed ID: 9988371
[TBL] [Abstract][Full Text] [Related]
16. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
Wang RB; Liu LT; Yiu CH; Chang TY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
[TBL] [Abstract][Full Text] [Related]
17. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the metabolites of carbamazepine in patient urine by liquid chromatography/mass spectrometry.
Maggs JL; Pirmohamed M; Kitteringham NR; Park BK
Drug Metab Dispos; 1997 Mar; 25(3):275-80. PubMed ID: 9172943
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of carbamazepine and its epoxide and diol metabolites in epileptic patients: the influence of dose and comedication.
Rambeck B; May T; Juergens U
Ther Drug Monit; 1987 Sep; 9(3):298-303. PubMed ID: 3672573
[TBL] [Abstract][Full Text] [Related]
20. Intradose and circadian variation in circulating carbamazepine and its epoxide in epileptic patients: a consequence of autoinduction of metabolism.
Macphee GJ; Butler E; Brodie MJ
Epilepsia; 1987; 28(3):286-94. PubMed ID: 3582293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
